Fortrea מציגה פתרון מקיף לשיפור הגיוון וההכללה במחקר קליני
31 mai 2024 13h24 HE
|
Fortrea Holdings Inc
ממנפת נתונים מהעולם האמיתי, תובנות מטופלים ותהליך שיטתי כדי לתכנן, להפעיל ולמדוד את האפקטיביות של תוכניות פעולה מגוונות בניסויים קליניים דורהאם, צפון קרוליינה, May 31, 2024 (GLOBE NEWSWIRE) -- ...
Fortrea stellt umfassende Lösung zur Verbesserung von Diversität und Inklusion in der klinischen Forschung vor
31 mai 2024 13h24 HE
|
Fortrea Holdings Inc
DURHAM, North Carolina, May 31, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (das „Unternehmen“), ein weltweit führendes Auftragsforschungsinstitut (Contract Research Organization, CRO), hat...
Fortrea 推出綜合解決方案來改善臨床研究中的多樣性和包容性
31 mai 2024 13h24 HE
|
Fortrea Holdings Inc
北卡羅來納州，達勒姆, June 01, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) （以下簡稱「公司」）是一家全球領先的合同研究組織 (CRO)，今天宣布推出全面的綜合一體化解決方案，以改善臨床試驗參與者的多樣性和包容性 (D&I)。Fortrea 的 D&I...
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
30 mai 2024 07h00 HE
|
Fortrea Holdings Inc
DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced its comprehensive and integrated...
Fortrea Appoints Machelle Sanders to Board of Directors
16 mai 2024 16h05 HE
|
Fortrea Holdings Inc
DURHAM, N.C., May 16, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the appointment of Machelle Sanders to...
Fortrea Reports First Quarter 2024 Results
13 mai 2024 06h30 HE
|
Fortrea Holdings Inc
For the three months ended March 31, 2024, from continuing operations: Revenues of $662.1 millionGAAP net loss of $81.6 millionAdjusted EBITDA of $29.5 millionGAAP and adjusted diluted earnings...
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
06 mai 2024 08h22 HE
|
Fortrea Holdings Inc
DURHAM, N.C., May 06, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced an updated issuance date for the...
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
11 avr. 2024 07h00 HE
|
Fortrea Holdings Inc
DURHAM, N.C., April 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter...
Fortrea unterzeichnet endgültige Vereinbarung zur Veräußerung der Geschäftsbereiche Endpoint Clinical und Patient Access an Arsenal Capital Partners
12 mars 2024 12h18 HE
|
Fortrea Holdings Inc
Vorgeschlagene Veräußerung der Geschäftsbereiche Endpoint Clinical und Fortrea Patient Access optimiert Fortreas strategische Ausrichtung als reines Auftragsforschungsinstitut Schafft eigenständige,...
Fortrea Assina Contrato Definitivo de Transferência das Unidades Endpoint Clinical e Patient Access para a Arsenal Capital Partners
12 mars 2024 12h18 HE
|
Fortrea Holdings Inc
A proposta da transferência das unidades Endpoint Clinical e Fortrea Patient Access agiliza ainda mais o foco estratégico da Fortrea como uma organização de pesquisa sob contrato Ela cria as melhores...